Is my paper relevant for an international audience?




Internationality, Global Health, Writing, Publishing, Biomedical Research, Research Design, Peer Review, Research, Quality Control, Editorial Policies, Periodicals as Topic


This is the first question one should consider before submitting a paper to an international journal. The answer is simple: If researchers or practitioners from another country can learn something from your paper that can influence a practice or a research they are involved in, then your paper is relevant for an international audience. There are many elements that can influence in this cross-border transferability. One could think that having a big “n”, or performing complex statistical calculations, or using complicated study designs makes the paper more attractive to colleagues from other countries. These elements can help, but they are not sufficient. On the other hand, one could think that a study performed in a small hospital in a given country will never be of interest for these foreign colleagues. That is not necessarily correct. Let’s burst some myths.


Download data is not yet available.


Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.

Garcia-Cardenas V, Armour C, Benrimoj SI, Martinez-Martinez F, Rotta I, Fernandez-Llimos F. Pharmacists' interventions on clinical asthma outcomes: a systematic review. Eur Respir J. 2016;47(4):1134-1143.

Rotta I, Salgado TM, Felix DC, Souza TT, Correr CJ, Fernandez-Llimos F. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract. 2015;21(4):584-590.

de Barra M, Scott C, Johnston M, De Bruin M, Scott N, Matheson C, Bond C, Watson M. Do pharmacy intervention reports adequately describe their interventions? A template for intervention description and replication analysis of reports included in a systematic review. BMJ Open. 2019;9(12):e025511.

Clay PG, Burns AL, Isetts BJ, Hirsch JD, Kliethermes MA, Planas LG. PaCIR: A tool to enhance pharmacist patient care intervention reporting. J Am Pharm Assoc (2003). 2019;59(5):615-623.

Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing clinical research. Philadelphia: Wolters; 2013.

Ioannidis JP. The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. Milbank Q. 2016;94(3):485-514.

Fan Y. Data reviews quick to produce but open to abuse. Nature. 2018;557(7703):31.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

Dingledine R. Why is it so hard to do good science? eNeuro. 2018;5(5):ENEURO.0188-18.2018.

Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011;45(5):626-629.

Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10:67.

Kwol VS, Eluwole KK, Avci T, Lasisi TT. Another look into the Knowledge Attitude Practice (KAP) model for food control: An investigation of the mediating role of food handlers’ attitudes. Food Control. 2020;110(4):107025.

Miller GE. The assessment of clinical skills/competence/performance. Acad Med. 1990;65(9 Suppl):S63-S67.




How to Cite

Fernandez-Llimos F. Is my paper relevant for an international audience?. Pharm Pract (Granada) [Internet]. 2020 Apr. 29 [cited 2021 Oct. 16];18(2):1924. Available from:

Most read articles by the same author(s)

1 2 > >>